PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
47.22
-0.64 (-1.34%)
At close: May 28, 2025, 4:00 PM
47.28
+0.06 (0.13%)
After-hours: May 28, 2025, 4:00 PM EDT
PTC Therapeutics Stock Forecast
Stock Price Forecast
According to 13 professional analysts, the 12-month price target for PTC Therapeutics stock ranges from a low of $40 to a high of $112. The average analyst price target of $62.31 forecasts a 31.96% increase in the stock price over the next year.
Price Target: $62.31 (+31.96%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PTC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 3 | 3 | 2 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $68 → $74 | Buy | Maintains | $68 → $74 | +56.71% | May 27, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $55 → $68 | Hold → Strong Buy | Upgrades | $55 → $68 | +44.01% | May 9, 2025 |
| Barclays | Barclays | Hold Maintains $56 → $42 | Hold | Maintains | $56 → $42 | -11.05% | May 8, 2025 |
| Baird | Baird | Buy Maintains $70 → $66 | Buy | Maintains | $70 → $66 | +39.77% | May 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $57 → $58 | Buy | Maintains | $57 → $58 | +22.83% | May 7, 2025 |
Financial Forecast
Revenue This Year
1.61B
from 806.78M
Increased by 99.06%
Revenue Next Year
865.26M
from 1.61B
Decreased by -46.12%
EPS This Year
4.88
from -4.73
EPS Next Year
-3.06
from 4.88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.9B | 1.0B | 1.6B | ||
| Avg | 1.6B | 865.3M | 1.1B | ||
| Low | 720.9M | 708.7M | 816.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 137.5% | -36.6% | 90.0% | ||
| Avg | 99.1% | -46.1% | 26.2% | ||
| Low | -10.6% | -55.9% | -5.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.57 | -0.64 | 9.50 | ||
| Avg | 4.88 | -3.06 | -0.57 | ||
| Low | -5.15 | -6.99 | -6.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.